 Meredith Tennis
Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Neoplasms | 18 | 2023 | 2207 | 2.880 |
Why?
| | Iloprost | 8 | 2023 | 46 | 2.700 |
Why?
| | Frizzled Receptors | 4 | 2022 | 23 | 1.790 |
Why?
| | Epoprostenol | 5 | 2021 | 133 | 1.740 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 6 | 2023 | 963 | 1.420 |
Why?
| | Smoke | 4 | 2020 | 133 | 1.170 |
Why?
| | Urethane | 4 | 2023 | 41 | 1.070 |
Why?
| | Wnt Proteins | 4 | 2012 | 135 | 1.050 |
Why?
| | MicroRNAs | 2 | 2022 | 607 | 0.870 |
Why?
| | Cigarette Smoking | 1 | 2022 | 80 | 0.730 |
Why?
| | Receptors, G-Protein-Coupled | 3 | 2010 | 192 | 0.680 |
Why?
| | PPAR gamma | 4 | 2022 | 185 | 0.630 |
Why?
| | Epithelial-Mesenchymal Transition | 2 | 2022 | 167 | 0.610 |
Why?
| | Chemoprevention | 3 | 2023 | 88 | 0.610 |
Why?
| | Anticarcinogenic Agents | 1 | 2018 | 67 | 0.600 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2010 | 314 | 0.600 |
Why?
| | Intracellular Signaling Peptides and Proteins | 3 | 2021 | 388 | 0.530 |
Why?
| | Precancerous Conditions | 3 | 2023 | 156 | 0.510 |
Why?
| | Epithelial Cells | 5 | 2022 | 961 | 0.450 |
Why?
| | Nerve Tissue Proteins | 2 | 2021 | 535 | 0.420 |
Why?
| | DNA (Cytosine-5-)-Methyltransferases | 1 | 2012 | 27 | 0.400 |
Why?
| | Carcinogens | 3 | 2022 | 105 | 0.390 |
Why?
| | Antihypertensive Agents | 2 | 2017 | 432 | 0.390 |
Why?
| | Mice | 10 | 2023 | 15052 | 0.390 |
Why?
| | Carcinoma, Squamous Cell | 3 | 2022 | 577 | 0.380 |
Why?
| | Cell Migration Inhibition | 1 | 2010 | 17 | 0.360 |
Why?
| | Signal Transduction | 5 | 2010 | 4541 | 0.360 |
Why?
| | Growth Inhibitors | 1 | 2010 | 45 | 0.360 |
Why?
| | Neoplasms, Second Primary | 1 | 2009 | 91 | 0.310 |
Why?
| | Adenocarcinoma | 2 | 2017 | 799 | 0.310 |
Why?
| | Glycoproteins | 1 | 2010 | 309 | 0.310 |
Why?
| | Lung | 7 | 2023 | 3672 | 0.300 |
Why?
| | DNA Methylation | 1 | 2012 | 498 | 0.300 |
Why?
| | Bronchi | 3 | 2018 | 250 | 0.300 |
Why?
| | Neoplasms, Experimental | 2 | 2018 | 153 | 0.290 |
Why?
| | Animals | 11 | 2023 | 32102 | 0.290 |
Why?
| | Gene Expression Regulation | 1 | 2016 | 2353 | 0.280 |
Why?
| | Smoking | 2 | 2012 | 1457 | 0.280 |
Why?
| | Breast Neoplasms | 3 | 2021 | 1872 | 0.270 |
Why?
| | Cell Movement | 1 | 2010 | 867 | 0.260 |
Why?
| | Cell Line, Tumor | 4 | 2022 | 2751 | 0.230 |
Why?
| | Mice, Transgenic | 3 | 2018 | 1970 | 0.230 |
Why?
| | Registries | 2 | 2009 | 1770 | 0.210 |
Why?
| | Disease Models, Animal | 2 | 2022 | 3580 | 0.200 |
Why?
| | Carcinoma, Intraductal, Noninfiltrating | 1 | 2021 | 50 | 0.190 |
Why?
| | Protein Domains | 1 | 2022 | 209 | 0.180 |
Why?
| | Carmustine | 1 | 2020 | 47 | 0.180 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2021 | 147 | 0.180 |
Why?
| | Carcinoma, Ductal, Breast | 1 | 2021 | 76 | 0.180 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2021 | 165 | 0.180 |
Why?
| | Carcinogenesis | 1 | 2021 | 178 | 0.180 |
Why?
| | Respiratory System | 1 | 2020 | 141 | 0.170 |
Why?
| | Cell Line | 2 | 2018 | 2651 | 0.170 |
Why?
| | Enzyme Inhibitors | 1 | 2022 | 757 | 0.160 |
Why?
| | Tobacco Smoking | 1 | 2018 | 21 | 0.160 |
Why?
| | Intramolecular Oxidoreductases | 1 | 2018 | 56 | 0.160 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2018 | 108 | 0.150 |
Why?
| | Tobacco Smoke Pollution | 1 | 2020 | 221 | 0.150 |
Why?
| | Protein Binding | 1 | 2022 | 1917 | 0.140 |
Why?
| | Humans | 15 | 2023 | 115587 | 0.130 |
Why?
| | Cells, Cultured | 2 | 2021 | 3914 | 0.110 |
Why?
| | DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2012 | 14 | 0.100 |
Why?
| | Cell Proliferation | 3 | 2018 | 2194 | 0.100 |
Why?
| | Immunohistochemistry | 2 | 2021 | 1642 | 0.100 |
Why?
| | Desmoglein 3 | 2 | 2022 | 17 | 0.090 |
Why?
| | Azacitidine | 1 | 2012 | 130 | 0.090 |
Why?
| | Thyroid Nuclear Factor 1 | 1 | 2009 | 14 | 0.090 |
Why?
| | Luciferases | 1 | 2010 | 140 | 0.090 |
Why?
| | Mesoderm | 1 | 2010 | 138 | 0.080 |
Why?
| | RNA, Messenger | 2 | 2022 | 2574 | 0.080 |
Why?
| | Neoplasm Invasiveness | 1 | 2010 | 445 | 0.080 |
Why?
| | Estrogen Receptor alpha | 1 | 2009 | 120 | 0.080 |
Why?
| | Tumor Cells, Cultured | 1 | 2010 | 850 | 0.080 |
Why?
| | Biomarkers | 1 | 2018 | 3466 | 0.080 |
Why?
| | Tumor Suppressor Proteins | 1 | 2010 | 286 | 0.080 |
Why?
| | Inflammation | 1 | 2018 | 2499 | 0.070 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 930 | 0.070 |
Why?
| | Treatment Outcome | 2 | 2018 | 9159 | 0.070 |
Why?
| | Promoter Regions, Genetic | 1 | 2012 | 1122 | 0.070 |
Why?
| | Vasodilator Agents | 1 | 2009 | 308 | 0.070 |
Why?
| | Neoplasm Metastasis | 1 | 2009 | 526 | 0.070 |
Why?
| | Blotting, Western | 1 | 2010 | 1153 | 0.070 |
Why?
| | Neoplasms, Radiation-Induced | 1 | 2005 | 65 | 0.060 |
Why?
| | Nuclear Proteins | 1 | 2009 | 594 | 0.060 |
Why?
| | Phenotype | 1 | 2012 | 2829 | 0.060 |
Why?
| | Formaldehyde | 1 | 2022 | 47 | 0.050 |
Why?
| | Female | 7 | 2022 | 59913 | 0.050 |
Why?
| | Keratin-5 | 1 | 2022 | 46 | 0.050 |
Why?
| | Algorithms | 1 | 2009 | 1490 | 0.050 |
Why?
| | Prognosis | 1 | 2009 | 3339 | 0.050 |
Why?
| | Transcription Factors | 1 | 2009 | 1528 | 0.050 |
Why?
| | Tubulin | 1 | 2022 | 123 | 0.050 |
Why?
| | Lung Diseases | 1 | 2008 | 710 | 0.050 |
Why?
| | Mice, Inbred A | 1 | 2020 | 45 | 0.050 |
Why?
| | Immunoblotting | 1 | 2021 | 281 | 0.050 |
Why?
| | gamma Catenin | 1 | 2018 | 17 | 0.040 |
Why?
| | Aged | 3 | 2018 | 19251 | 0.040 |
Why?
| | Metaplasia | 1 | 2018 | 54 | 0.040 |
Why?
| | Bronchial Diseases | 1 | 2018 | 38 | 0.040 |
Why?
| | Cell Cycle Checkpoints | 1 | 2018 | 84 | 0.040 |
Why?
| | Receptors, Prostaglandin | 1 | 2017 | 22 | 0.040 |
Why?
| | Biological Availability | 1 | 2017 | 119 | 0.040 |
Why?
| | Receptors, CXCR4 | 1 | 2017 | 78 | 0.040 |
Why?
| | Hydrogels | 1 | 2023 | 581 | 0.040 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2017 | 166 | 0.040 |
Why?
| | Middle Aged | 3 | 2018 | 26999 | 0.030 |
Why?
| | Proto-Oncogene Proteins | 1 | 2018 | 609 | 0.030 |
Why?
| | Biopsy | 1 | 2018 | 1056 | 0.030 |
Why?
| | Cell Cycle Proteins | 1 | 2018 | 553 | 0.030 |
Why?
| | Macrophages | 1 | 2020 | 1284 | 0.030 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2018 | 1147 | 0.030 |
Why?
| | Disease Progression | 1 | 2018 | 2418 | 0.020 |
Why?
| | Drug Design | 1 | 2008 | 156 | 0.020 |
Why?
| | Cobalt Radioisotopes | 1 | 2005 | 6 | 0.020 |
Why?
| | Cocarcinogenesis | 1 | 2005 | 14 | 0.020 |
Why?
| | Radiation, Ionizing | 1 | 2005 | 73 | 0.020 |
Why?
| | Radiotherapy Dosage | 1 | 2005 | 246 | 0.020 |
Why?
| | Radiotherapy | 1 | 2005 | 177 | 0.020 |
Why?
| | Odds Ratio | 1 | 2005 | 962 | 0.010 |
Why?
| | Adult | 1 | 2018 | 30718 | 0.010 |
Why?
| | Time Factors | 1 | 2005 | 6165 | 0.010 |
Why?
| | Male | 1 | 2018 | 55949 | 0.010 |
Why?
| | Risk Factors | 1 | 2005 | 8697 | 0.010 |
Why?
|
|
Tennis's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|